Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients

Abstract

In conclusion, serum miR-494 was significantly elevated in NSCLC patients and closely correlated with poor clinical outcome, indicating that serum miR-494 might be a useful diagnostic and prognostic marker for NSCLC.